Fig. 4.

Timeline of the study. Timepoints of the two-phase study depicting the three clinical visits (V1, V2 and V3) and the seven telephone interviews (T1-T7) are shown. Timing for HCPI and CBPI administration to the owners are also indicated. The cut-off for pain control following the two-week administration of full dose meloxicam is shown (bottom left) and the criteria for continuing the study from T2 onward is also indicated (bottom right). Dotted lines represent timepoints in which the criteria for the maintenance of pain relief were checked